The Medicines Company to Participate in the Bank of America Merrill Lynch 2019 Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 7, 2019--The Medicines Company (NASDAQ:MDCO) announced that it will participate in the Bank of America Merrill Lynch 2019 Healthcare Conference on Tuesday, May 14, 2019, in Las Vegas. The Company is scheduled to present at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time).
A live audio webcast will be available on The Medicines Company Investor Relations website and a replay of the presentation will be available within 48 hours of the event.
About The Medicines Company
The Medicines Company is a biopharmaceutical company whose purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C, or bad cholesterol. Our team is focused on transformational solutions that address the daily challenges that patients, physicians and payers confront in cardiovascular care. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190507005079/en/
CONTACT: Investor Relations
Krishna Gorti, M.D.
Vice President, Investor Relations
973 290 6122
Vice President, Communications
973 290 6100
KEYWORD: UNITED STATES NORTH AMERICA NEVADA NEW JERSEY
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CARDIOLOGY PHARMACEUTICAL
SOURCE: The Medicines Company
Copyright Business Wire 2019.
PUB: 05/07/2019 07:00 AM/DISC: 05/07/2019 07:01 AM